STOCK TITAN
  1. Home
  2. Sec-filings
  3. SOPH
  4. [EFFECT] SOPHiA GENETICS SA SEC Filing

[EFFECT] SOPHiA GENETICS SA SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 6, 2026 4:00 P.M.
Form: F-3
CIK: 0001840706
Company Name: SOPHiA GENETICS SA
File Number: 333-293970

Source: View Original Filing on SEC EDGAR

Sophia Genetics Sa

NASDAQ:SOPH

View SOPH Stock Overview →

SOPH Rankings

#4099 Ranked by Market Cap
N/A Ranked by Dividends

SOPH Latest News

Mar 3, 2026
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results
Feb 25, 2026
SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference
Feb 17, 2026
SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026
Feb 10, 2026
SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems
Jan 15, 2026
United Rentals, Inc. Fourth Quarter and Full Year 2025 Conference Call and Audio Webcast Thursday, January 29, 2026 at 8:30 a.m. (ET)

SOPH Latest SEC Filings

Mar 6, 2026
[424B3] SOPHiA GENETICS SA Prospectus Filed Pursuant to Rule 424(b)(3)
Mar 3, 2026
[F-3] SOPHiA GENETICS SA Foreign Issuer Shelf Registration
Mar 3, 2026
[20-F] SOPHiA GENETICS SA Files Annual Report (Foreign Issuer)
Mar 3, 2026
[6-K] SOPHiA GENETICS SA Current Report (Foreign Issuer)
Feb 19, 2026
[144] SOPHiA GENETICS SA SEC Filing

SOPH Stock Data

295.13M
63.48M
Health Information Services
Healthcare
Link
Switzerland
Rolle